Advaxis Stock Price (NASDAQ:ADXS)

Add to My Stocks
$8.31 $0.04 (0.48%) ADXS stock closing price Apr 25, 2017 (Closing)
25 APR 2017
amigobulls logo
ADXS hand_up
ADXS vs S&P 500
Closing Price: Apr 25, 2017
$8.31 ( 0.48%)
S&P 500
2388.6 ( 0.61%)
52 Week Price Range
1 Year Return: -10.4%
Q1 Growth*
Profitable ?
net image
2017 Q1 Net Loss
Pays Dividend ?
12 Months Dividend
  : $0
Dividend Yield
  : -99900%
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Advaxis Snapshot Video

12 5 2

ADXS Stock Details

Prev Close* : $8.27
Market Cap:
Day Low: $8.27
52 Week Low: $6.47
Open: $8.33
Volume: 464803
Day High: $8.58
52 Week High: $16.30

Latest Stock Market News

Latest Articles

Advaxis News - From Partners

ADXS Stockcharts

View ADXS PE ratio, PS ratio stocks charts and compare with peers.
ADXS Chart
Note: Compare Advaxis stock price history with the index and industry peers.

Advaxis Financial Ratios

Asset Turnover
Receivables Turnover

ADXS Industry Peers

Company Price Change (%)
Theratechnologies (THERF)4.760.15 (3.25%)
Sinovac Biotech (SVA)5.630.01 (0.18%)
Aratana Therapeutics (PETX)6.040.07 (1.15%)
Astrazeneca (AZN)30.490.25 (0.83%)
Aduro Biotech (ADRO)9.60.3 (3.23%)
Inovio Pharma (INO)6.790.26 (3.98%)
Agenus (AGEN)3.70.1 (2.78%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Epizyme (EPZM)17.452.55 (17.11%)
Sangamo BioSciences (SGMO)4.750.45 (10.47%)
Fortress Biotech (FBIO)3.570.29 (8.84%)
Idera Pharma (IDRA)2.4350.19 (8.44%)
Achillion Pharma (ACHN)3.480.27 (8.41%)
Revance (RVNC)22.451.55 (7.42%)
Immunomedics (IMMU)5.440.36 (7.08%)
Top gainers from Medical-Biomed-Genetics industry
* As of Apr 26, 2017
CompanyPriceChange (%)
AKARI THERAPTC (AKTX)15.252.24 (12.81%)
The Medicines Company (MDCO)49.112.34 (4.55%)
Kindred Biosciences (KIN)6.850.3 (4.2%)
ALBIREO PHARMA (ALBO)21.610.37 (1.68%)
Repligen (RGEN)34.630.48 (1.37%)
Cara Therapeutics (CARA)16.390.22 (1.32%)
NOVELION THERAP (NVLN)10.090.12 (1.18%)
Top losers from Medical-Biomed-Genetics industry
* As of Apr 26, 2017

Advaxis, Inc. Stock News - Partner Headlines

Advaxis Financial Statements

income statement20162015201420132012
Net Sales Or Revenues3.99M-1M--
Net Income-73.55M-47.03M-16.52M-19.98M-12.06M
Total Operating Expense80.48M48.67M20.53M14.69M12.32M
view Advaxis, Inc. income statement
balance sheet20162015201420132012
Total Assets169.04M119.6M23.37M23.58M3.81M
Total Liabilities49.74M4M2.74M5.58M9.77M
Shareholders Equity119.3M115.59M20.62M18M-5.96M
view Advaxis, Inc. balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities39.85M1.02M-4.54M-0.27M5.87M
Net Cash From (Used By) Operating Activities-9.07M-24.13M-17.02M-8.71M-4.56M
Increase (Decrease) In Prop Plant And Equipment-3.22M-0.97M-0.02M-0.02M-0.09M
view Advaxis, Inc. cashflow statement

Advaxis Stock Message Board

An investor needs to spend 8.31 to buy ADXS stock, as the closing Advaxis stock price is 8.31. Looking at Advaxis market capitalization, which currently stands at 333.24M, we can say that ADXS stock is a Small cap stock. Advaxis valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

For recognizing and analyzing the real performance of Advaxis stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 464803 ADXS shares were traded yesterday, and Advaxis stock chart shows that the ADXS stock quote hit a day high of 8.58 and day low of 8.27. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Advaxis stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.